Review timelines for generic drugs in the Philippines are set to be slashed dramatically, as part of efforts spearheaded by the country’s president to speed up new drug approvals and bring down medicines prices.
“On the directive of president Ferdinand R. Marcos Jr., the FDA is set to shorten the period of review and...